Kirn David
SEC CIK 1834021 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| FDMT | 4D Molecular Therapeutics, Inc. | See Remarks, Dir | 767.5K | — | $12.53M | 20 | 2022-12-15 | 2026-09-14 |
Most active insiders at FDMT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Kirn David | See Remarks, Dir | — | $4.26M |
| 2 | Bizily Scott | CLO | — | $387.7K |
| 3 | Gupta Ashoo | VP, Fin, Ctrl | — | $6,734 |
| 4 | THEUER CHARLES | Dir | — | — |
Transactions 20
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-16 17:13 | 2026-09-14 | FDMT | 4D Molecular Therapeutics, Inc. | Kirn David | See Remarks, Dir | S - Sale | $13.90 | -58.3K | 767.5K | -7% | -$811.0K |
| DT | 2026-08-21 16:06 | 2026-08-19 | FDMT | 4D Molecular Therapeutics, Inc. | Kirn David | See Remarks, Dir | M - OptEx | $4.14 | +50.0K | 894.9K | +6% | +$207.0K |
| DMT | 2026-08-21 16:06 | 2026-08-19 | FDMT | 4D Molecular Therapeutics, Inc. | Kirn David | See Remarks, Dir | S - Sale+OE | $15.75 | -69.1K | 825.8K | -8% | -$1.09M |
| T | 2026-08-05 16:10 | 2026-08-04 | FDMT | 4D Molecular Therapeutics, Inc. | Kirn David | See Remarks, Dir | S - Sale | $10.23 | -26.8K | 844.9K | -3% | -$274.6K |
| T | 2026-08-04 16:45 | 2026-08-03 | FDMT | 4D Molecular Therapeutics, Inc. | Kirn David | See Remarks, Dir | S - Sale | $10.05 | -12.4K | 871.7K | -1% | -$124.7K |
| MT | 2026-07-14 17:04 | 2026-07-09+ | FDMT | 4D Molecular Therapeutics, Inc. | Kirn David | See Remarks, Dir | S - Sale | $12.64 | -58.3K | 884.2K | -6% | -$737.4K |
| T | 2026-06-23 16:19 | 2026-06-22 | FDMT | 4D Molecular Therapeutics, Inc. | Kirn David | See Remarks, Dir | S - Sale | $10.47 | -114.7K | 942.5K | -11% | -$1.20M |
| T | 2026-06-02 16:48 | 2026-06-01 | FDMT | 4D Molecular Therapeutics, Inc. | Kirn David | See Remarks, Dir | S - Sale | $10.02 | -1,922 | 1.06M | -0.2% | -$19.3K |
| DMT | 2024-07-12 | 2024-07-10 | FDMT | 4D Molecular Therapeutics, Inc. | Kirn David | CEO, Dir | M - OptEx | $14.55 | +12.9K | 1.07M | +1% | +$188.1K |
| DT | 2024-07-12 | 2024-07-10 | FDMT | 4D Molecular Therapeutics, Inc. | Kirn David | CEO, Dir | S - Sale+OE | $22.49 | -12.9K | 1.06M | -1% | -$290.6K |
| DT | 2024-06-26 | 2024-06-24 | FDMT | 4D Molecular Therapeutics, Inc. | Kirn David | CEO, Dir | S - Sale+OE | $23.10 | -12.9K | 1.06M | -1% | -$298.7K |
| DT | 2024-06-26 | 2024-06-24 | FDMT | 4D Molecular Therapeutics, Inc. | Kirn David | CEO, Dir | M - OptEx | $14.42 | +12.9K | 1.07M | +1% | +$186.5K |
| T | 2024-02-12 | 2024-02-08 | FDMT | 4D Molecular Therapeutics, Inc. | Kirn David | CEO, Dir | S - Sale | $27.13 | -92.0K | 1.06M | -8% | -$2.50M |
| 2024-01-25 | 2024-01-23 | FDMT | 4D Molecular Therapeutics, Inc. | Kirn David | CEO, Dir | S - Sale | $18.41 | -5,696 | 1.15M | -0.5% | -$104.9K | |
| MT | 2024-01-08 | 2023-12-15+ | FDMT | 4D Molecular Therapeutics, Inc. | Kirn David | CEO, Dir | S - Sale | $19.15 | -102.3K | 1.19M | -8% | -$1.96M |
| 2023-05-04 | 2023-05-02 | FDMT | 4D Molecular Therapeutics, Inc. | Kirn David | CEO, Dir | G - Gift | $0.00 | -600.0K | 1.26M | -32% | $0 | |
| I | 2023-05-04 | 2023-05-02 | FDMT | 4D Molecular Therapeutics, Inc. | Kirn David | CEO, Dir | G - Gift | $0.00 | +600.0K | 600.0K | New | $0 |
| M | 2023-02-23 | 2023-02-21+ | FDMT | 4D Molecular Therapeutics, Inc. | Kirn David | CEO, Dir | S - Sale | $20.61 | -34.4K | 1.88M | -2% | -$709.8K |
| M | 2023-01-23 | 2023-01-19+ | FDMT | 4D Molecular Therapeutics, Inc. | Kirn David | CEO, Dir | S - Sale | $20.10 | -19.5K | 1.90M | -1% | -$392.4K |
| M | 2022-12-19 | 2022-12-15+ | FDMT | 4D Molecular Therapeutics, Inc. | Kirn David | CEO, Dir, 10% | S - Sale | $23.23 | -86.9K | 1.97M | -4% | -$2.02M |
Purchase Sale Sale after option exercise All abbreviations